0.13
-0.0048(-3.69%)
Currency In USD
| Previous Close | 0.13 |
| Open | 0.12 |
| Day High | 0.13 |
| Day Low | 0.12 |
| 52-Week High | 17.17 |
| 52-Week Low | 0.1 |
| Volume | 2.27M |
| Average Volume | 16.58M |
| Market Cap | 10.01M |
| PE | -4.17 |
| EPS | -0.03 |
| Moving Average 50 Days | 0.44 |
| Moving Average 200 Days | 1.24 |
| Change | -0 |
If you invested $1000 in AEON Biopharma, Inc. (AEON) since IPO date, it would be worth $13.61 as of February 05, 2025 at a share price of $0.125. Whereas If you bought $1000 worth of AEON Biopharma, Inc. (AEON) shares 1 year ago, it would be worth $13.48 as of February 05, 2025 at a share price of $0.125.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
GlobeNewswire Inc.
Jan 07, 2025 2:37 PM GMT
IRVINE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced the c
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
GlobeNewswire Inc.
Jan 06, 2025 2:00 PM GMT
IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced the p
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
GlobeNewswire Inc.
Jan 04, 2025 1:02 AM GMT
IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today annou